MATTHEW JOHNSON: Open Payments
NPI 1669607800 · BISBEE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$190 in 10 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $83 · 2025 $190
Food & beverage: $140Long term medical supply or device loan: $50
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $81 |
| Abbott Laboratories | 1 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: FREESTYLE INSULINX, OTEZLA, REPATHA, EVENITY, ZENPEP, CAPLYTA, BYETTA, BREZTRI.
Industry payments across AZ — which companies pay providers there.
